Buschard Karsten, Thomassen Katrin, Lynge Elsebeth, Vejborg Ilse, Tjønneland Anne, von Euler-Chelpin My, Andersen Zorana Jovanovic
Bartholin Institute, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Department of Public Health, Center for Epidemiology and Screening, University of Copenhagen, Øster Farimagsgade 5, 1014, Copenhagen, Denmark.
Cancer Causes Control. 2017 Jan;28(1):13-21. doi: 10.1007/s10552-016-0829-z. Epub 2016 Nov 10.
We examined whether diabetes and diabetes treatment are associated with MD in a cohort study of Danish women above age of 50 years.
Study cohort consisted of 5,644 women (4,500 postmenopausal) who participated in the Danish Diet, Cancer, and Health cohort (1993-1997) and subsequently attended mammographic screening in Copenhagen (1993-2001). We used MD assessed at the first screening after the cohort entry, defined as mixed/dense or fatty. Diabetes diagnoses and diabetes treatments (diet, insulin, or oral antidiabetic agents) were self-reported at the time of recruitment (1993-1997). The association between MD and diabetes was analyzed by logistic regression adjusted for potential confounders. Effect modification by menopausal status and body mass index (BMI) was performed by introducing an interaction term into the model and tested by Wald test.
Of 5,644 women with mean age of 56 years, 137 (2.4%) had diabetes and 3,180 (56.3%) had mixed/dense breasts. Having diabetes was significantly inversely associated with having mixed/dense breasts, in both, the crude model (odds ratio; 95% confidence interval: 0.33; 0.23-0.48), and after adjustment for adiposity and other risk factors (0.61; 0.40-0.92). Similar inverse associations were observed for 44 women who controlled diabetes by diet only and did not receive any medication (0.56; 0.27-1.14), and 62 who took oral antidiabetic agents only for diabetes (0.59; 0.32-1.09), while women taking insulin had increased odds of mixed/dense breasts (2.08; 0.68-6.35). There was no effect modification of these associations by menopausal status or BMI.
Having diabetes controlled by diet or oral antidiabetic agents is associated with a decrease in MD, whereas taking insulin is associated with an increase in MD.
在一项针对50岁以上丹麦女性的队列研究中,我们研究了糖尿病及糖尿病治疗与乳腺密度(MD)之间是否存在关联。
研究队列由5644名女性(4500名绝经后女性)组成,她们参与了丹麦饮食、癌症与健康队列研究(1993 - 1997年),随后在哥本哈根接受了乳腺钼靶筛查(1993 - 2001年)。我们使用队列入组后首次筛查时评估的乳腺密度,定义为混合型/致密型或脂肪型。糖尿病诊断和糖尿病治疗(饮食、胰岛素或口服降糖药)在招募时(1993 - 1997年)通过自我报告获得。通过对潜在混杂因素进行调整的逻辑回归分析乳腺密度与糖尿病之间的关联。通过在模型中引入交互项并进行Wald检验,对绝经状态和体重指数(BMI)的效应修饰进行分析。
在平均年龄为56岁的5644名女性中,137名(2.4%)患有糖尿病,3180名(56.3%)为混合型/致密型乳腺。在原始模型(比值比;95%置信区间:0.33;0.23 - 0.48)以及在对肥胖和其他风险因素进行调整后(0.61;0.40 - 0.92),患有糖尿病均与混合型/致密型乳腺显著负相关。对于仅通过饮食控制糖尿病且未接受任何药物治疗的44名女性(0.56;0.27 - 1.14)以及仅服用口服降糖药治疗糖尿病的62名女性(0.59;0.32 - 1.09),观察到了类似的负相关,而使用胰岛素的女性出现混合型/致密型乳腺的几率增加(2.08;0.68 - 6.35)。这些关联在绝经状态或BMI方面不存在效应修饰。
通过饮食或口服降糖药控制糖尿病与乳腺密度降低相关,而使用胰岛素与乳腺密度增加相关。